Paul Lab

Profile

Our focus is upon the improvement of the therapeutic and diagnostic possibilities for neuroimmunological diseases, especially for multiple sclerosis.

We are working on this with a translational approach; this means that we try to transfer new developments and findings from basic research directly into clinical work.

Further information on our website

Here you can find the press release concerning our latest results.

Publications

May 01, 2019 in Neurol Neuroimmunol Neuroinflamm

Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica

B. Pasquier et al.

April 10, 2019 in Neurology

Damage of the lateral geniculate nucleus in MS: assessing the missing node of the visual pathway

A. Papadopoulou et al.

April 01, 2019 in Mult Scler J

Multiple sclerosis-related fatigue: altered resting-state functional connectivity of the ventral striatum and dorsolateral prefrontal cortex

S. Jaeger et al.

April 01, 2019 in Mult Scler J

Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis

C. Graetz et al.

March 11, 2019 in J Neuroinflamm

Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study

M.N. Olesen et al.

March 09, 2019 in Ann Neurol

Optimal inter-eye difference thresholds by OCT in MS: an international study

R.C. Nolan et al.

March 01, 2019 in Semin Immunopathol

Sex differences in autoimmune disorders of the central nervous system

S.M. Gold et al.

February 28, 2019 in J Neuroinflammation

Myelinoclastic diffuse sclerosis (Schilder's disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar punctures

S. Jarius et al.

February 05, 2019 in Dev Med Child Neurol

The use of magnetic resonance imaging in the diagnosis of paediatric transverse myelitis

F. Paul

February 01, 2019 in J Neurol

Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS)

A. Johnen et al.